-+ 0.00%
-+ 0.00%
-+ 0.00%

Veeva Teams Up with Sarah Cannon to Speed Up Cancer Trials at 200+ Research Sites

Benzinga·06/04/2025 11:07:16
Listen to the news

Veeva Systems (NYSE:VEEV) and Sarah Cannon Research Institute (SCRI) today announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI's more than 200 research site locations. SCRI is adopting Veeva Clinical Platform to unify its contract research organization (CRO) and site management organization (SMO) on a single platform for seamless data flow across clinical teams and research sites.